BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12376396)

  • 1. Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats.
    Bertram D; Blanc-Brunat N; Sassard J; Lo M
    Am J Physiol Regul Integr Comp Physiol; 2002 Nov; 283(5):R1041-5. PubMed ID: 12376396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G; Liu KL; Chapuis B; Lo M
    Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure and proteinuria after cessation of a brief renin-angiotensin system blockade in young and adult Lyon hypertensive rats.
    Naelten G; Trigo LF; Lo M
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):740-5. PubMed ID: 16306796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes.
    Mervaala E; Dehmel B; Gross V; Lippoldt A; Bohlender J; Milia AF; Ganten D; Luft FC
    J Am Soc Nephrol; 1999 Aug; 10(8):1669-80. PubMed ID: 10446934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
    Sachetelli S; Liu Q; Zhang SL; Liu F; Hsieh TJ; Brezniceanu ML; Guo DF; Filep JG; Ingelfinger JR; Sigmund CD; Hamet P; Chan JS
    Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
    Emonnot L; Cohen R; Lo M
    Am J Hypertens; 2008 Jun; 21(6):657-62. PubMed ID: 18443571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-week inhibition of the renin-angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks.
    Byars SG; Prestes PR; Suphapimol V; Takeuchi F; De Vries N; Maier MC; Melo M; Balding D; Samani N; Allen AM; Kato N; Wilkinson-Berka JL; Charchar F; Harrap SB
    Cardiovasc Res; 2024 May; 120(7):769-781. PubMed ID: 38501595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage.
    Amann K; Simonaviciene A; Medwedewa T; Koch A; Orth S; Gross ML; Haas C; Kuhlmann A; Linz W; Schölkens B; Ritz E
    J Am Soc Nephrol; 2001 Dec; 12(12):2572-2584. PubMed ID: 11729225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
    Wagner J; Drab M; Bohlender J; Amann K; Wienen W; Ganten D
    Clin Exp Hypertens; 1998 Feb; 20(2):205-21. PubMed ID: 9533614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation.
    Bidani AK; Griffin KA; Bakris G; Picken MM
    Kidney Int; 2000 Apr; 57(4):1651-61. PubMed ID: 10760100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
    Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
    Lantelme P; Lo M; Sassard J
    Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
    Gao XM; Tsai A; Al-Sharea A; Su Y; Moore S; Han LP; Kiriazis H; Dart AM; Murphy AJ; Du XJ
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):145-156. PubMed ID: 28204966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G; Hertenberg F; Wetzels JF; Smits P
    J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.
    Cao Z; Cooper ME; Wu LL; Cox AJ; Jandeleit-Dahm K; Kelly DJ; Gilbert RE
    Hypertension; 2000 Oct; 36(4):561-8. PubMed ID: 11040236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
    Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
    Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In the Lyon hypertensive rat, renal function alterations are angiotensin II dependent.
    Liu KL; Sassard J; Benzoni D
    Am J Physiol; 1996 Aug; 271(2 Pt 2):R346-51. PubMed ID: 8770133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combined administration of ACE inhibitor and angiotensin II receptor antagonist are prevented by a high NaCl intake.
    Griffiths CD; Morgan TO; Delbridge LM
    J Hypertens; 2001 Nov; 19(11):2087-95. PubMed ID: 11677376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotection persists after cessation of treatment with very low doses of perindopril in Lyon hypertensive rats.
    Egan EJ; Dijoud F; Gilibert S; Sassard J
    Acta Pharmacol Sin; 2008 Nov; 29(11):1296-300. PubMed ID: 18954523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.